Humacyte, Inc. Files 8-K on Shareholder Votes & Financials
Ticker: HUMAW · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1818382
| Field | Detail |
|---|---|
| Company | Humacyte, Inc. (HUMAW) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, financial-reporting
TL;DR
Humacyte filed an 8-K on June 10th covering shareholder votes and financials.
AI Summary
Humacyte, Inc. filed an 8-K on June 10, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, formerly Alpha Healthcare Acquisition Corp., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing provides updates on corporate actions and financial reporting, which are crucial for investors to understand the company's current status and governance.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating new or significant risks.
Key Players & Entities
- Humacyte, Inc. (company) — Registrant
- Alpha Healthcare Acquisition Corp. (company) — Former Company Name
- June 10, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific matters were submitted to a vote of Humacyte, Inc.'s security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not elaborated upon in the provided text.
What type of financial statements are being reported in this 8-K filing?
The filing states that 'Financial Statements and Exhibits' are being submitted, but the specific nature or period of these financial statements is not detailed in the excerpt.
When was Humacyte, Inc. formerly known as Alpha Healthcare Acquisition Corp.?
The date of the name change from Alpha Healthcare Acquisition Corp. to Humacyte, Inc. was July 16, 2020.
What is Humacyte, Inc.'s principal executive office address?
Humacyte, Inc.'s principal executive offices are located at 2525 East North Carolina Highway 54, Durham, NC 27713.
What is the SIC code for Humacyte, Inc.?
Humacyte, Inc.'s Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Humacyte, Inc. (HUMAW).